Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

Abbott India Limited's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.00000
forwardPE 32.18395
debtToEquity 4.54900
earningsGrowth 0.04200
revenueGrowth 0.06800
grossMargins 0.46409
operatingMargins 0.25794
trailingEps 717.85000
forwardEps 817.02220

With positive gross and operating margins, Abbott India Limited demonstrates strong profitability. This reflects the company's ability to manage costs and maintain healthy profits, showcasing effective operational efficiency and financial stability.
Abbott India Limited's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that Abbott India Limited's financial performance will improve in the current financial year.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

ABBOTINDIA's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts are favoring ABBOTINDIA with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider ABBOTINDIA as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.